Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation (2023)
Attributed to:
Targeting endothelial-erythrocyte glycocalyx exchange for the novel diagnosis and treatment of renal disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.medj.2023.09.002
PubMed Identifier: 37863058
Publication URI: http://europepmc.org/abstract/MED/37863058
Type: Journal Article/Review
Parent Publication: Med
Issue: 11
ISSN: 2666-6340